Assessment of diabetic nephropathy in the Akita mouse

Methods in Molecular Biology

Volumn 933, Issue , 2012, Pages 17-29

  Chang, Jae Hyung ^a   Gurley, Susan B ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

24 h urine collection; Albuminuria; Angiotensin converting enzyme 2; Bradykinin receptor; Diabetic nephropathy; Endothelial nitric oxide synthase; Genetic susceptibility; Glomerular filtration rate; Ketogenic diet; Mouse metabolic cage; Mouse model of type I diabetes

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; ENZYME DEFICIENCY; GENE; INS2 GENE; INSULIN DEPENDENT DIABETES MELLITUS; KETOGENESIS; KIDNEY INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 84934440597     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-68-7_2     Document Type: Article

References (44)

1. Reutens AT, Atkins RC (2011) Epidemiology of diabetic nephropathy. Contrib Nephrol 170:1-7
2. de Boer IH et al (2011) Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 305:2532-2539
3. (2003) USRDS: the United States Renal Data System. Am J Kidney Dis 42:1-230
4. Chavers BM et al (1989) Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med 320:966-970
5. Dalla VM et al (2000) Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab 26(Suppl 4):8-14
6. Breyer MD et al (2005) Mouse models of diabetic nephropathy. J Am Soc Nephrol 16: 27-45
7. Brosius FC 3rd et al (2009) Mouse models of diabetic nephropathy. J Am Soc Nephrol 20: 2503-2512
8. Gurley SB et al (2010) Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice. Am J Physiol Renal Physiol 298:F788-795
9. Gurley SB et al (2006) Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 290:F214-222
10. Yoshioka M et al (1997) A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46: 887-894
11. Ron D (2002) Proteotoxicity in the endoplasmic reticulum: lessons from the Akita diabetic mouse. J Clin Invest 109:443-445
12. Cowie CC (1993) Diabetic renal disease: racial and ethnic differences from an epidemiologic perspective. Transplant Proc 25:2426-2430
13. Qi Z et al (2005) Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes 54:2628-2637
14. Kakoki M, Smithies O (2009) The kallikreinkinin system in health and in diseases of the kidney. Kidney Int 75:1019-1030
15. Kakoki M et al (2010) Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice. Proc Natl Acad Sci U S A 107:10190-10195
16. Kakoki M et al (2004) Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor. Proc Natl Acad Sci U S A 101:13302-13305
17. Rigat B et al (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346
18. Gurley SB, Coffman TM (2007) The reninangiotensin system and diabetic nephropathy. Semin Nephrol 27:144-152
19. Lewis EJ et al (1993) The effect of angiotensinconverting- enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329:1456-1462
20. Spillmann F et al (2002) Regulation of cardiac bradykinin B1- and B2-receptor mRNA in experimental ischemic, diabetic, and pressure- overloadinduced cardiomyopathy. Int Immunopharmacol 2:1823-1832
21. Schremmer-Danninger E et al (1998) B1 bradykinin receptors and carboxypeptidase M are both upregulated in the aorta of pigs after LPS infusion. Biochem Biophys Res Commun 243:246-252
22. Ahluwalia A, Perretti M (1999) B1 receptors as a new in flammatory target. Could this B the 1? Trends Pharmacol Sci 20:100-104
23. Chopra B et al (2005) Expression and function of bradykinin B1 and B2 receptors in normal and in flamed rat urinary bladder urothelium. J Physiol 562:859-871
24. Duka I et al (2001) Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertension. Circ Res 88:275-281
25. Futrakul N et al (2006) Early detection of endothelial injury and dysfunction in conjunction with correction of hemodynamic maladjustment can effectively restore renal function in type 2 diabetic nephropathy. Clin Hemorheol Microcirc 34:373-381
26. Ignarro LJ et al (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 84:9265-9269
27. Bogdan C (2001) Nitric oxide and the immune response. Nat Immunol 2:907-916
28. Zanchi A et al (2000) Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 57:405-413
29. Ksiazek P et al (2003) Endothelial nitric oxide synthase gene intron 4 polymorphism in type 2 diabetes mellitus. Mol Diagn 7:119-123
30. Ezzidi I et al (2008) Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786 T > C gene variants with diabetic nephropathy. J Diabetes Complications 22: 331-338
31. Wang CH et al (2011) A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy. Proc Natl Acad Sci U S A 108:2070-2075
32. Tikellis C et al (2003) Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 41:392-397
33. Wysocki J et al (2006) ACE and ACE2 activity in diabetic mice. Diabetes 55:2132-2139
34. Ye M et al (2004) Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? Hypertension 43:1120-1125
35. Mizuiri S et al (2008) Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls. Am J Kidney Dis 51:613-623
36. Reich HN et al (2008) Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int 74:1610-1616
37. Wong DW et al (2007) Loss of angiotensinconverting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 171:438-451
38. Oudit GY et al (2010) Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes 59:529-538
39. Poplawski MM et al (2011) Reversal of diabetic nephropathy by a ketogenic diet. PLoS One 6:e18604
40. Al-Khalifa A et al (2009) Therapeutic role of low-carbohydrate ketogenic diet in diabetes. Nutrition 25:1177-1185
41. Badman MK et al (2009) A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independent of weight loss. Am J Physiol Endocrinol Metab 297(5): E1197-204
42. Chmiel-Perzynska I et al (2011) Novel aspect of ketone action: beta-hydroxybutyrate increases brain synthesis of kynurenic acid in vitro. Neurotox Res 20:40-50
43. Ma W, Berg J, Yellen G (2007) Ketogenic diet metabolites reduce firing in central neurons by opening K(ATP) channels. J Neurosci 27:3618-3625
44. Hong EG et al (2007) Nonobese, insulinde ficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling. Am J Physiol Endocrinol Metab 293:E1687-1696